Tuminello Stephanie, Kaufman Andrew J, Wolf Andrea, Lee Dong-Seok, Hakami-Kermani Ardeshir, Housman Brian, Nicastri Daniel G, Taioli Emanuela, Flores Raja M
Department of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Institute for Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
J Thorac Dis. 2025 Aug 31;17(8):5492-5498. doi: 10.21037/jtd-2025-741. Epub 2025 Aug 21.
Mounting evidence suggests that lung cancers differ meaningfully between those with and without a smoking history, including clinical and biological differences that may impact treatment efficiency. However, there is a dearth of real-world, patient-level evidence comparing demographic, clinical, tumor and surgical characteristics of lung cancers among those who have never ever smoked, as well as surgical outcomes. This study sought to fill these research gaps.
Information on patient characteristics, including smoking history, and surgical outcomes was extracted from a real-world thoracic surgery database in New York City. Pearson tests and Spearman tests were used for univariate analysis comparing patients with and without a smoking history; outcomes of surgery were assessed using multivariable logistic regression.
Among 1,587 surgically treated lung cancer patients, 332 (20.9%) were cases of lung cancer among those who had never smoked (LCNS) 1,255 (79.1%) cases of lung cancer among those who had ever smoked (LCES). LCNS patients were younger, more likely to be female, and Hispanic; these patients also appeared to be healthier in pre-operative assessment and to have a higher likelihood of lobectomy compared to wedge surgical resection. LCNS tumors were more likely to be adenocarcinoma or neuroendocrine, be located in the lower lobe, and carry mutations (P>0.05 for all univariate comparisons). Post-surgical outcomes appear to be better for LCNS patients; the relative odds of both additional lung surgery [adjusted odds ratio (OR): 0.53; 95% confidence interval (CI): 0.28-0.94] and mortality (OR: 0.57; 95% CI: 0.34-0.93) were lower in LCNS LCES patients, even after adjustment for confounding; odds of post-surgical complications were lower among LCNS patients, but this was not statistically significant.
LCNS and LCES surgical patients differ meaningfully in terms of clino-demographic factors. Our results support surgery as a safe and effective treatment option for LCNS.
越来越多的证据表明,有吸烟史和无吸烟史的肺癌患者在很多方面存在显著差异,包括可能影响治疗效果的临床和生物学差异。然而,目前缺乏真实世界中患者层面的证据,来比较从不吸烟、曾经吸烟的肺癌患者的人口统计学、临床、肿瘤及手术特征,以及手术结果。本研究旨在填补这些研究空白。
从纽约市一个真实世界的胸外科数据库中提取患者特征信息,包括吸烟史和手术结果。采用Pearson检验和Spearman检验进行单因素分析,比较有吸烟史和无吸烟史的患者;使用多变量逻辑回归评估手术结果。
在1587例接受手术治疗的肺癌患者中,332例(20.9%)为从不吸烟肺癌患者(LCNS),1255例(79.1%)为曾经吸烟肺癌患者(LCES)。LCNS患者更年轻,女性和西班牙裔比例更高;与楔形手术切除相比,这些患者在术前评估中似乎更健康,接受肺叶切除术的可能性更高。LCNS肿瘤更可能为腺癌或神经内分泌癌,位于下叶,且携带突变(所有单因素比较P>0.05)。LCNS患者术后结果似乎更好;即使在调整混杂因素后,LCNS患者再次进行肺部手术的相对比值(调整后比值比[OR]:0.53;95%置信区间[CI]:0.28 - 0.94)和死亡率(OR:0.57;95%CI:0.34 - 0.93)均低于LCES患者;LCNS患者术后并发症的发生率较低,但差异无统计学意义。
LCNS和LCES手术患者在临床人口统计学因素方面存在显著差异。我们的结果支持手术作为LCNS的一种安全有效的治疗选择。